novo nordisk weight loss - Search News

News

Novo Nordisk ousts CEO

The New York Times · 9h

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Reuters on MSN · 4h

Novo Nordisk ousts CEO after falling behind in weight loss market

Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

The Associated Press - Busines… · 2h

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the company’s board of directors, citing “recent market challenges” and a steep decline in the company’s share price.

3h

Novo Nordisk announces CEO transition as share price slips

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...

4hon MSN

Novo Nordisk, U.S. biotech company team up to create obesity pills

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

7h

Why Novo Nordisk Stock Just Slipped

Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.

Indianapolis Business Journal2d

Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results